The HIV care cascade and antiretroviral therapy in female sex workers: Implications for HIV prevention

Expert Review of Anti-Infective Therapy

Volumn 12, Issue 10, 2014, Pages 1203-1219

  Mountain, Elisa ^a   Pickles, Michael ^a   Mishra, Sharmistha ^a,b,c   Vickerman, Peter ^d   Alary, Michel ^e,f,g   Boily, Marie Claude ^a,e,f  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e University Laval   (Canada)

^f UNIVERSITÉ LAVAL   (Canada)

^g INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

antiretroviral therapy; female sex worker; HIV care cascade; mathematical modeling; review

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL THERAPY; FEMALE; HEALTH CARE; HEALTH IMPACT ASSESSMENT; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RISK; MEDICATION COMPLIANCE; PATIENT COUNSELING; PRACTICE GUIDELINE; PROSTITUTION; REVIEW; SEXUAL BEHAVIOR; VIRUS INHIBITION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; HIV INFECTIONS; PATIENT COMPLIANCE; THEORETICAL MODEL; TRANSMISSION;

ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MODELS, THEORETICAL; PATIENT COMPLIANCE; SEX WORKERS;

EID: 84907051628     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2014.948422     Document Type: Review

References (121)

1. Mehta M, Semitala F, Lynen L, Colebunders R. Antiretroviral treatment in low-resource settings: what has changed in the last 10 years and what needs to change in the coming years? Expert Rev Anti Infect Ther 2012;10:1287-96
2. WHO. The strategic use of antiretrovirals to help end the HIV epidemic. WHO; Geneva, Switzerland: 2012
3. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. WHO; Geneva, Switzerland: 2013
4. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach-2010 revision. WHO; Geneva, Switzerland: 2010
5. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505
6. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010;375:2092-8
7. HIV Modelling Consortium Treatment as Prevention Editorial Writing Group. HIV treatment as prevention: models, data, and questions-towards evidence-based decision-making. PLoS Med 2012;9: e1001259
8. WHO. Antiretroviral treatment as prevention (TasP) of HIV and TB: 2012 update. WHO; Geneva, Switzerland: 2012
9. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009;23:1397-404
10. Hallett TB, Eaton JW. A side door into care cascade for HIV-infected patients? J Acquir Immune Defic Syndr 2013; 63(Suppl 2)):S228-32
11. Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011;52:793-800
12. Hull MW, Wu Z, Montaner JS. Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as prevention. Curr Opin HIV AIDS 2012;7:579-86
13. Kranzer K, Govindasamy D, Ford N, et al. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc 2012;15:17383
14. Alary M, Lowndes CM. The central role of clients of female sex workers in the dynamics of heterosexual HIV transmission in sub-Saharan Africa. AIDS 2004;18:945-7
15. Alary M, Lowndes CM, Van de Perre P, et al. Scale-up of combination prevention and antiretroviral therapy for female sex workers in West Africa: time for action. AIDS 2013;27(9):1369-74
16. Baral S, Beyrer C, Muessig K, et al. Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 2012;12(7):538-49
17. Boily MC, Lowndes C, Alary M. The impact of HIV epidemic phases on the effectiveness of core group interventions: insights from mathematical models. Sex Transm Infect 2002;78(Suppl 1)):i78-90
18. Cote AM, Sobela F, Dzokoto A, et al. Transactional sex is the driving force in the dynamics of HIV in Accra, Ghana. AIDS 2004;18:917-25
19. Vickerman P, Foss AM, Pickles M, et al. To what extent is the HIV epidemic in southern India driven by commercial sex? A modelling analysis. AIDS 2010;24: 2563-72
20. WHO. Prevention and treatment of HIV and other sexually transmitted infections for sex workers in low-and middle-income countries: recommendations for a public health approach. WHO; Geneva, Switzerland: 2012
21. Platt L, Jolley E, Rhodes T, et al. Factors mediating HIV risk among female sex workers in Europe: a systematic review and ecological analysis. BMJ Open 2013;3(7): e002836
22. Rapid Response Service. Rapid response: sex worker HIV risk ontario HIV treatment network. 2012
23. National collaborating centre for infectious disease. Evidence review: interventions for the prevention of the sexual transmission of HIV among female sex workers and their clients and non paying partners in Canada. 2012
24. Baral S, Todd CS, Aumakhan B, et al. HIV among female sex workers in the Central Asian Republics, Afghanistan, and Mongolia: contexts and convergence with drug use. Drug Alcohol Depend 2013;132: S13-16
25. Boltaev AA, El-Bassel N, Deryabina AP, et al. Scaling up HIV prevention efforts targeting people who inject drugs in Central Asia: a review of key challenges and ways forward. Drug Alcohol Depend 2013;132: S41-7
26. El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA. Drug use as a driver of HIV risks: re-emerging and emerging issues. Curr Opin HIV AIDS 2014;9:150-5
27. Patterson TL, Semple SJ, Staines H, et al. Prevalence and correlates of HIV infection among female sex workers in 2 Mexico-US border cities. J Infect Dis 2008;197:728-32
28. Strathdee SA, Abramovitz D, Lozada R, et al. Reductions in HIV/STI incidence and sharing of injection equipment among female sex workers who inject drugs: results from a randomized controlled trial. PLoS One 2013;8(6):e65812
29. Strathdee SA, Philbin MM, Semple SJ, et al. Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug Alcohol Depend 2008;92:132-40
30. Delva W, Eaton JW, Meng F, et al. HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med 2012;9(7): e1001258
31. Wilson D, Halperin DT. 'Know your epidemic, know your response': a useful approach, if we get it right. Lancet 2008;372:423-6
32. WHO. Service delivery approaches to HIV testing and counselling (HTC): a strategic HTC policy framework. WHO; Geneva, Switzerland: 2012
33. WHO. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. WHO; Geneva, Switzerland: 2011
34. Guest P, Prohmmo A, Bryant J, et al. 2007 Survey of. Sexual and Reproductive Health of Sex Workers in Thailand. Institute for Population and Social Research, Mahidol University 2007; Edison Press Products Co Ltd, Bangkok
35. Ngo AD, Ratliff EA, McCurdy SA, et al. Health-seeking behaviour for sexually transmitted infections and HIV testing among female sex workers in Vietnam. AIDS Care 2007;19:878-87
36. Nhurod P, Bollen LJ, Smutraprapoot P, et al. Access to HIV testing for sex workers in Bangkok, Thailand: a high prevalence of HIV among street-based sex workers. Southeast Asian J Trop Med Public Health 2010;41:153-62
37. NACO. TI program performance analysis-2010-11. 2012
38. UNAIDS. Global report: UNAIDS Report on the global AIDS epidemic 2012. 2012
39. USAID. DHS Comparative reports no. 30 demographic patterns of HIV testing uptake in Sub-Saharan Africa. 2013
40. Hong Y, Zhang C, Li X, et al. HIV testing behaviors among female sex workers in Southwest China. AIDS Behav 2012;16: 44-52
41. Wang Y, Li B, Zheng J, et al. Factors related to female sex workers' willingness to utilize VCT service: a qualitative study in Jinan city, Northern China. AIDS Behav 2009;13:866-72
42. Severe P, Juste MA, Ambroise A, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med 2010;363:257-65
43. Siegfried N, Uthman OA, Rutherford GW. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev 2010;CD008272
44. Strategies for Management of Antiretroviral Therapy Study Group. Emery S, Neuhaus JA, Phillips AN, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis 2008;197:1133-44
45. Mugglin C, Estill J, Wandeler G, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health 2012; 17(12):1509-20
46. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011;8:e1001056
47. Braunstein SL, Umulisa MM, Veldhuijzen NJ, et al. HIV diagnosis, linkage to HIV care, and HIV risk behaviors among newly diagnosed HIV-positive female sex workers in Kigali, Rwanda. J Acquir Immune Defic Syndr 2011;57:e70-6
48. Kayigamba FR, Bakker MI, Fikse H, et al. Patient enrolment into HIV care and treatment within 90 days of HIV diagnosis in eight rwandan health facilities: a review of facility-based registers. PLoS One 2012; 7(5):e36792
49. Mountain E, Mishra S, Vickerman P, et al. Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis. PLoS One 2014
50. Graham SM, Rajwans N, Jaoko W, et al. Endothelial activation biomarkers increase after HIV-1 acquisition: plasma vascular cell adhesion molecule-1 predicts disease progression. AIDS 2013;27:1803-13
51. Kilmarx PH, Limpakarnjanarat K, Kaewkungwal J, et al. Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand. J Infect Dis 2000;181:1598-606
52. Konate I, Traore L, Ouedraogo A, et al. Linking HIV prevention and care for community interventions among high-risk women in Burkina Faso-. the ARNS 1222 'Yerelon' cohort. J Acquir Immune Defic Syndr 2011;57(Suppl 1)):S50-4
53. McClelland L, Wanje G, Kashonga F, et al. Understanding the context of HIV risk behavior among HIV-positive and HIV-negative female sex workers and male bar clients following antiretroviral therapy rollout in Mombasa, Kenya. AIDS Educ Prev 2011;23:299-312
54. McClelland RS, Graham SM, Richardson BA, et al. Treatment with antiretroviral therapy is not associated with increased sexual risk behavior in Kenyan female sex workers. AIDS 2010;24:891-7
55. Balkus JE, Richardson BA, Mochache V, et al. A prospective cohort study comparing the effect of single-dose 2 G metronidazole on trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women. Sex Transm Dis 2013;40:499-505
56. Becker ML, Mishra S, Satyanarayana et al. Rates and determinants of HIV-attributable mortality among rural female sex workers in Northern Karnataka, India. Int J STD AIDS 2012;23:36-40
57. Chakrapani V, Newman PA, Shunmugam M, et al. Barriers to free antiretroviral treatment access for female sex workers in Chennai, India. AIDS Patient Care STDS 2009;23:973-80
58. Comulada WS, Swendeman DT, Rotheram-Borus MJ, et al. Use of HAART among young people living with HIV. Am J Health Behav 2003;27:389-400
59. Cowan FM, Mtetwa S, Davey C, et al. Engagement with HIV prevention treatment and care among female sex workers in Zimbabwe: a respondent driven sampling survey. PLoS One 2013;8(10):e77080
60. Cox J, Maurais E, Hu L, et al. Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort. Drug Alcohol Depend 2014;137:121-8
61. Dennis AM, Murillo W, De Maria Hernandez F, et al. Social network-based recruitment successfully reveals HIV-1 transmission networks among high-risk individuals in El Salvador. J Acquir Immune Defic Syndr 2013;63: 135-41
62. Donastorg Y, Barrington C, Perez M, Kerrigan D. Abriendo Puertas: baseline Findings from an Integrated Intervention to Promote Prevention, Treatment and Care among FSW Living with HIV in the Dominican Republic. PLoS One 2014;9: e88157
63. Jadhav A, Bhattacharjee P, Raghavendra T, et al. Risky Behaviors among HIV-Positive Female Sex Workers in Northern Karnataka, India. AIDS Res Treat 2013;2013:878151
64. Kalokhe AS, Paranjape A, Bell CE, et al. Intimate partner violence among HIV-infected crack cocaine users. AIDS Patient Care STDS 2012;26:234-40
65. Lester RT, Yao XD, Ball TB, et al. HIV-1 RNA dysregulates the natural TLR response to subclinical endotoxemia in Kenyan female sex-workers. PLoS One 2009;4(5):e5644
66. Low AJ, Konate I, Nagot N, et al. Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso. Sex Transm Infect 2014;90:100-3
67. Masese LN, Graham SM, Gitau R, et al. A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy. BMC Infect Dis 2011;11:307
68. McKinnon LR, Kimani M, Wachihi C, et al. Effect of baseline HIV disease parameters on CD4+ T cell recovery after antiretroviral therapy initiation in Kenyan women. PLoS One 2010;5:e11434
69. Reddon H, Wood E, Tyndall M, et al. Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users. AIDS Educ Prev 2011;23:412-22
70. Schuelter-Trevisol F, da Silva MV, Oliveira CM, Rodrigues R. HIV genotyping among female sex workers in the State of Santa Catarina. Rev Soc Bras Med Trop 2007;40:259-63
71. Shannon K, Bright V, Duddy J, Tyndall MW. Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside. J Urban Health 2005;82:488-97
72. Tyurina A, Krupitsky E, Cheng DM, et al. Is cannabis use associated with HIV drug and sex risk behaviors among Russian HIV-infected risky drinkers? Drug Alcohol Depend 2013;132:74-80
73. Dean J, Ta Thi TH, Dunford L, et al. Prevalence of HIV type 1 antiretroviral drug resistance mutations in Vietnam: a multicenter study. AIDS Res Hum Retroviruses 2011;27:797-801
74. Graham SM, Mugo P, Gichuru E, et al. Adherence to antiretroviral therapy and clinical outcomes among young adults reporting high-risk sexual behavior, including men who have sex with men, in coastal Kenya. AIDS Behav 2013;17: 1255-65
75. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 2007;4:1691-701
76. Graham SM, Jalalian-Lechak Z, Shafi J, et al. Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA. J Acquir Immune Defic Syndr 2012;60: 511-18
77. Graham SM, Masese L, Gitau R, et al. Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment. J Infect Dis 2010;202: 1538-42
78. Huet C, Ouedraogo A, Konate I, et al. Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa. BMC Public Health 2011;11:700
79. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health 2010;15(Suppl 1)):1-15
80. Mtetwa S, Busza J, Chidiya S, et al. 'You are wasting our drugs': health service barriers to HIV treatment for sex workers in Zimbabwe. BMC Public Health 2013;13:698
81. Turner BJ. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis 2002; 185(Suppl 2)):S143-51
82. Dieffenbach CW. Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda. Curr Opin HIV AIDS 2012;7:106-10
83. Thaker HK, Snow MH. HIV viral suppression in the era of antiretroviral therapy. Postgrad Med J 2003;79:36-42
84. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30
85. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis 2006;43:939-41
86. Deering KN, Shannon K, Sinclair H, et al. Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDS 2009;23:603-9
87. Graham SM, Holte SE, Peshu NM, et al. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS 2007;21:501-7
88. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006;296:679-90
89. Ortego C, Huedo-Medina TB, Santos P, et al. Sex differences in adherence to highly active antiretroviral therapy: a meta-analysis. AIDS Care 2012;24:1519-34
90. Diabate S, Zannou DM, Geraldo N, et al. Antiretroviral therapy among HIV-1 infected female sex workers in benin: a comparative study with patients from the general population. World J AIDS 2011;1: 94-9
91. Low AJ, Konate I, Nagot N, et al. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in burkina faso: a longitudinal study. J Acquir Immune Defic Syndr 2014;65:237-45
92. Kato M, Granich R, Duc Bui D, et al. The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: Towards elimination of HIV transmission. J Acquir Immune Defic Syndr 2013;63(5):e142-9
93. Mishra S, Mountain E, Pickles M, et al. Exploring the population-level impact of antiretroviral treatment: the influence of baseline intervention context. AIDS 2013; 27(Suppl 0):S1-S12
94. Nagelkerke NJ, Jha P, de Vlas SJ, et al. Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. Bull World Health Organ 2002;80:89-96
95. Eaton J, Menzies N, Stover J, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health 2014;2:e23-34
96. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS 2010;24:2665-78
97. McMahon JH, Elliott JH, Hong SY, et al. Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review. PLoS One 2013;8:e56047
98. Kilmarx PH, Mutasa-Apollo T. Patching a leaky pipe: the cascade of HIV care. Curr Opin HIV AIDS 2013;8:59-64
99. Miller WC, Lesko CR, Powers KA. The HIV Care Cascade: simple Concept, Complex Realization. Sex Transm Dis 2014;41:41-2
100. Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis 2013;57:1164-71
101. INS, CDC, UCSF, Pathfinder, I-TECH. Final report: the integrated biological and behavioural survey among female sex workers. UCSF; Mozambique; 2011-2012
102. Aho J, Nguyen VK, Diakite S, et al. High acceptability of HIV voluntary counselling and testing among female sex workers: impact of individual and social factors. HIV Med 2012;13:156-65
103. Shannon K, Strathdee SA, Goldenberg SM, et al. Global epidemiology of HIV among female sex workers: influence of structural determinants. Lancet 2014; doi:10.1016/S0140-6736(14)60931-4
104. Rekart ML. Sex-work harm reduction. Lancet 2005;366:2123-34
105. Scheibe A, Drame FM, Shannon K. HIV prevention among female sex workers in Africa. SAHARA J 2012;9:167-72
106. Duff P, Tyndall M, Buxton J, et al. Sex-for-Crack exchanges: Associations with risky sexual and drug use niches in an urban Canadian city. Harm Reduct J 2013;10:29
107. Shannon K, Bright V, Allinott S, et al. Community-based HIV prevention research among substance-using women in survival sex work: The Maka Project Partnership. Harm Reduct J 2007;4:20
108. Spire B, Lucas GM, Carrieri MP. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy 2007;18:262-70
109. Vera A, Abramovitz D, Lozada R, et al. Mujer Mas Segura (Safer Women): a combination prevention intervention to reduce sexual and injection risks among female sex workers who inject drugs. BMC Public Health 2012;12:653
110. Wodak A, McLeod L. The role of harm reduction in controlling HIV among injecting drug users. AIDS 2008; 22(Suppl 2)):S81-92
111. Boily M, Mishra S. Examining the population level impact of scaling-up ART for FSWs across epidemic contexts. Oral presentation presented at The international society for sexually transmitted diseases research; Vienna; 2013
112. Boily M, Shubber Z. Modelling in Concentrated Epidemics: informing epidemic trajectories and assessing prevention approaches. Curr Opin HIV AIDS 2014;9(2):134-49
113. Mishra S, Pickles M, Blanchard JF, et al. Distinguishing sources of HIV transmission from the distribution of newly acquired HIV infections: why is it important for HIV prevention planning? Sex Transm Infect 2014;90(1):19-25
114. Mishra S. The ART cascade among female sex workers in India. Oral presentation presented at The international society for sexually transmitted diseases research; Vienna; 2013
115. Mishra S, Steen R, Gerbase A, et al. Impact of high-risk sex and focused interventions in heterosexual HIV epidemics: a systematic review of mathematical models. PLoS One 2012;7(11):e50691
116. Hallett TB, Garnett GP, Mupamberiyi Z, Gregson S. Measuring effectiveness in community randomized trials of HIV prevention. Int J Epidemiol 2008;37:77-87
117. Gurnani V, Beattie TS, Bhattacharjee P, et al. An integrated structural intervention to reduce vulnerability to HIV and sexually transmitted infections among female sex workers in Karnataka state, south India. BMC Public Health 2011;11:755
118. KHPT, ICRW, UNDP, STRIVE. Gaurav: Reducing HIV-related stigma among female sex workers. 2013
119. Rojanapithayakorn W. The 100% condom use programme in Asia. Reprod Health Matters 2006;14:41-52
120. STRIVE. A global HIV stigma reduction framework adapted and implemented in five settings in India. 2013
121. Scaling up of HIV treatment programs among the most at-risk populations in low-and middle-income countries. Symposium at the international society for sexually transmitted diseases research; Vienna; 2013